<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01128751</url>
  </required_header>
  <id_info>
    <org_study_id>P41/09// A67/09</org_study_id>
    <nct_id>NCT01128751</nct_id>
  </id_info>
  <brief_title>Elimination of Microemboli During Aortic Valve Replacement</brief_title>
  <acronym>ELMAR</acronym>
  <official_title>ELMAR - Elimination of Microemboli During Aortic Valve Replacement. A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Else Kröner Fresenius Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Giessen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a randomized controlled trial patients undergoing aortic valve replacement are recruited
      into 3 groups. Patients receive either an intra-aortic filter (Embol-X), designed to reduce
      solid microemboli during mechanical surgical intervention, a dynamic bubble-trap (DBT),
      designed to reduce gaseous microemboli from cardiopulmonary bypass (CPB), or no additional
      device (control-group). Cognitive functioning is assessed 3 weeks to 1 day before and 3
      months (+/- 1 week) after valve replacement. Furthermore, cerebral magnetic resonance imaging
      (MRI) is carried 2-6 days after surgery. Primary endpoint is the cognitive outcome of the
      filter groups compared to the controls. Secondary endpoint is the number of acute ischemic
      lesions after CABG.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuropsychological assessment 1</measure>
    <time_frame>3 weeks to 1 day before intervention</time_frame>
    <description>Patients are assessed by an extensive neuropsychological test battery to test cognitive functions and psychological measures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological assessment 2</measure>
    <time_frame>3 months (+/- 1 week) post intervention</time_frame>
    <description>Patients are assessed by an extensive neuropsychological test battery to test cognitive functions and psychological measures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MRI lesions detected after surgery</measure>
    <time_frame>2-6 days postoperative</time_frame>
    <description>In MRI micro-embolic lesions are detected using diffusion weighted imaging (DWI)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Neurocognitive Outcome After Aortic Valve Replacement</condition>
  <arm_group>
    <arm_group_label>Embol-X</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm receive intra-aortic filter designed to catch solid debris for neuroprotection during surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DBT dynamic bubble trap</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm receive a dynamic bubble trap to reduce gaseous micro-emboli from cardiopulmonary bypass for neuroprotection during surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In comparison to arm 1 and 2, patients in this arm do not receive an additional intervention during surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Embol-X intra-aortic emboli filter</intervention_name>
    <description>Patients in this arm receive intra-aortic filter designed to catch solid debris for neuroprotection during surgery.</description>
    <arm_group_label>Embol-X</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DBT dynamic bubble trap</intervention_name>
    <description>Patients in this arm receive a dynamic bubble trap to reduce gaseous micro-emboli from cardiopulmonary bypass for neuroprotection during surgery</description>
    <arm_group_label>DBT dynamic bubble trap</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>In comparison to arm 1 and 2, patients in this arm do not receive an additional intervention during surgery</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18

          -  Elective aortic valve replacement

          -  Informed consent

          -  German language

        Exclusion Criteria:

          -  Neurological and psychiatric diseases that would conflict with neuropsychological
             testing (e.g. stroke, TBI, schizophrenia, etc.); further major surgeries on CPB
             planned for within 3 months after valve replacement

          -  Contraindication against MRI assessment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Niko Schwarz, PhD</last_name>
    <phone>+49(0)6032/999-</phone>
    <phone_ext>5811</phone_ext>
    <email>niko.schwarz@neuro.med.uni-giessen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tibo Gerriets, MD</last_name>
    <phone>+40(0)6032/999-</phone>
    <phone_ext>5812</phone_ext>
    <email>tibo.gerriets@neuro.med.uni-giessen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Clinic Giessen</name>
      <address>
        <city>35392 Giessen</city>
        <state>Hessen</state>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jörn Bohn</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johann Wolfgang Goehte University Clinic</name>
      <address>
        <city>60590 Frankfurt</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Annika Löffler</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kerckhoff Clinic</name>
      <address>
        <city>61231 Bad Nauheim</city>
        <state>Hessen</state>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Niko Schwarz, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2010</study_first_submitted>
  <study_first_submitted_qc>May 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2010</study_first_posted>
  <last_update_submitted>May 21, 2010</last_update_submitted>
  <last_update_submitted_qc>May 21, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 24, 2010</last_update_posted>
  <responsible_party>
    <name_title>PD Dr. Tibo Gerriets</name_title>
    <organization>Justus Liebig University, Department of Neurology</organization>
  </responsible_party>
  <keyword>Cognition</keyword>
  <keyword>Neuroprotection</keyword>
  <keyword>Cardiopulmonary bypass</keyword>
  <keyword>Aortic valve replacement</keyword>
  <keyword>Micro-emboli</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

